Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:moxifloxacin
|
| gptkbp:approvalYear |
2003
|
| gptkbp:ATCCode |
S01AE07
|
| gptkbp:concentration |
0.5% moxifloxacin
|
| gptkbp:contraindication |
hypersensitivity to moxifloxacin
|
| gptkbp:drugClass |
fluoroquinolone antibiotic
|
| gptkbp:form |
gptkb:eye_drops
|
| gptkbp:indication |
bacterial conjunctivitis
|
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
topical (eye)
|
| gptkbp:sideEffect |
blurred vision
eye irritation dry eye |
| gptkbp:bfsParent |
gptkb:Valeant_Pharmaceuticals
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vigamox
|